Currently, several prognostic factors have been identified, including tumor size, regional lymph node (LN) involvement, the presence of distant metastasis, age, histologic grade, the presence of lymphovascular invasion, hormone receptor, and human epidermal growth factor receptor 2 (HER2) status. The gene discussed is ERBB2; the disease is neoplasm.